menu ☰
menu ˟

[Correspondence] Informed use of bedaquiline for tuberculosis–Authors' reply

02 May 2015

We thank Erica Lessem and colleagues for commenting on our Viewpoint1 regarding the challenges surrounding the bedaquiline patient registry in the USA. For drugs like bedaquiline that receive accelerated approval, patient registries are a critical mechanism for collecting safety data on new drugs. Recent data from the US Centers for Disease Control and Prevention indicate that the tuberculosis epidemic in the USA is marked by increasing racial and ethnic disparities, and concentrated among foreign-born people.

Click here to view the full article which appeared in The Lancet